After delivering solid sales growth in a difficult 2025, Germany’s Merck KGaA may have a tougher go of things this year, which the company is crediting in part to a predicted onslaught of U.S.
A blockbuster drug is a best-selling medication earning over $1 billion annually. Learn about them and how they revolutionize ...
A commentary by FDA officials Vinay Prasad, MD, MPH, and Martin Makary, MD, MPH, details the new system for drug approvals in the US. FDA Commissioner Martin Makary, MD, MPH, and his top deputy Vinay ...
HARTFORD, Conn. (WFSB) - A new Connecticut law that took effect January 1 prohibits manufacturers and wholesale distributors from increasing generic prescription drug prices beyond the annual rate of ...
In legislation enacted on Feb. 3, 2026, Congress reauthorized the rare pediatric disease priority review voucher program, clarified the scope of orphan drug exclusivity (ODE) and mandated increased ...
For months, President Donald Trump and his aides touted efforts to lower prescription drug prices for Americans. Now consumers can check prices at the recently launched website TrumpRx.gov. "This is a ...
BOISE, Idaho — Idaho Attorney General Raúl Labrador has joined a coalition of 48 states and territories in announcing $17.85 million in settlements with pharmaceutical companies Lannett Company, Inc.
Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss the fight between Novo Nordisk and Hims & Hers over GLP-1 drugs, immunization policies in the U.S., and more. 'Everyone here is ...
John Wilkerson is a Washington correspondent for STAT who writes about the politics of health care. He is also the author of the twice-weekly D.C. Diagnosis newsletter. Emory is the data editor at ...
Freedom from the Robinson-Patman Act Is Never More Than One Generation Away from Extinction AI Laws Need a Kill Switch The Great Inversion Unicorns in Sweden The Duty to Say What the Law Is Capping ...
Replacing animal testing with alternate methodologies in preclinical drug trials holds potential for the development of cheaper, safer pharmaceuticals as well as alleviating animal suffering. But ...